Faulty Heart Devices Costly for Medicare, Consumers

FDA officials announce new testing procedures for implantable heart devices after it was revealed Medicare has spent $1.5 billion to replace faulty devices.

Copyright Disclaimer:This article has been RSS syndicated and was originally published here.